TNF-R Antibodies

Santa Cruz Biotechnology features a diverse variety of TNF-R monoclonal antibodies for immunology and cell signaling research. TNF-R monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Tumor Necrosis Factor Receptors (TNF-R) mediate the effects of tumor necrosis factor (TNF), a key cytokine involved in inflammation and immune responses. The activation of TNF-R regulates cell survival, apoptosis, and inflammatory response, making TNF-R significant in various diseases, including autoimmune disorders and cancer. Understanding TNF-R function is crucial for developing targeted therapies and advancing knowledge of immune system dynamics. Research into TNF-R signaling pathways continues to reveal new insights about cellular communication and disease mechanisms. TNF-R investigation has led to breakthroughs in understanding inflammatory conditions and potential therapeutic approaches. Exploring TNF-R signaling networks helps identify novel treatment strategies for immune-related disorders. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of TNF-R biology and its impact on human health.